Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,561 | 381 | 98.8% |
| Education | $67.27 | 8 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $733.27 | 31 | $0 (2021) |
| Novo Nordisk Inc | $673.69 | 51 | $0 (2024) |
| PFIZER INC. | $444.06 | 40 | $0 (2022) |
| GlaxoSmithKline, LLC. | $435.81 | 23 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $415.48 | 55 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $348.32 | 29 | $0 (2019) |
| Lilly USA, LLC | $330.63 | 29 | $0 (2019) |
| Amgen Inc. | $207.75 | 11 | $0 (2019) |
| ParaPRO, LLC | $200.00 | 1 | $0 (2021) |
| Amarin Pharma Inc. | $179.46 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $157.34 | 4 | Medtronic, Inc. ($100.51) |
| 2023 | $252.51 | 4 | GlaxoSmithKline, LLC. ($125.00) |
| 2022 | $29.43 | 2 | Dynavax Technologies Corporation ($14.79) |
| 2021 | $325.00 | 2 | ParaPRO, LLC ($200.00) |
| 2019 | $877.27 | 58 | Novo Nordisk Inc ($152.89) |
| 2018 | $2,132 | 158 | AstraZeneca Pharmaceuticals LP ($384.46) |
| 2017 | $1,855 | 161 | Janssen Pharmaceuticals, Inc ($203.47) |
All Payment Transactions
389 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Diabetes Care | ||||||
| 10/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Obesity | ||||||
| 02/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Diabetes Care | ||||||
| 01/30/2024 | Medtronic, Inc. | SIGNIA (Device) | Food and Beverage | In-kind items and services | $100.51 | General |
| Category: Surgical Stapling | ||||||
| 10/09/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Education | In-kind items and services | $14.66 | General |
| Category: Gastroenterology | ||||||
| 04/19/2023 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $4.25 | General |
| Category: Pain Management | ||||||
| 03/08/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: VACCINES | ||||||
| 03/02/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $108.60 | General |
| Category: Obesity | ||||||
| 10/20/2022 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Hepatitis B Vaccine | ||||||
| 06/07/2022 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: VACCINES | ||||||
| 09/03/2021 | ParaPRO, LLC | Natroba (Drug) | Food and Beverage | Cash or cash equivalent | $200.00 | General |
| Category: HeadLice | ||||||
| 06/24/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2019 | Tactile Systems Technology Inc | FLEXITOUCH (Device), ACTITOUCH, ENTRE | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 06/12/2019 | Ironshore Pharmaceuticals Inc. | Jornay PM 20mg capsules (Bottle of 100) (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Central nervous system (CNS) stimulant | ||||||
| 06/11/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Diabetes | ||||||
| 06/06/2019 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Hypertriglyceridemia | ||||||
| 06/03/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Diabetes | ||||||
| 05/22/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Diabetes | ||||||
| 05/17/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Neuroscience | ||||||
| 05/16/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Diabetes | ||||||
| 05/14/2019 | Nalpropion Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: OBESITY | ||||||
| 05/10/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/08/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/07/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 978 | 1,331 | $139,817 | $68,711 |
| 2022 | 15 | 1,031 | 1,377 | $140,006 | $66,155 |
| 2021 | 13 | 949 | 1,264 | $133,740 | $64,734 |
| 2020 | 15 | 896 | 1,200 | $110,614 | $39,549 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 270 | 493 | $83,810 | $37,744 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 161 | $19,320 | $8,756 | 45.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 69 | 69 | $11,385 | $8,481 | 74.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $4,270 | $3,946 | 92.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 269 | 348 | $6,960 | $2,923 | 42.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 39 | 39 | $3,300 | $2,795 | 84.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $2,940 | $1,887 | 64.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 42 | $1,050 | $1,029 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 34 | 39 | $2,340 | $371.28 | 15.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $375.00 | $367.50 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 15 | $1,305 | $119.02 | 9.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 21 | 24 | $600.00 | $74.64 | 12.4% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 13 | 13 | $871.00 | $73.58 | 8.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 31 | 33 | $759.00 | $72.60 | 9.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 14 | 14 | $532.00 | $71.12 | 13.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 258 | 473 | $80,410 | $35,943 | 44.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 71 | 71 | $11,715 | $8,739 | 74.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 131 | 170 | $20,400 | $8,340 | 40.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 58 | 59 | $4,710 | $3,969 | 84.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 24 | 24 | $5,880 | $3,683 | 62.6% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 13 | 13 | $1,810 | $1,704 | 94.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 59 | 60 | $1,500 | $1,471 | 98.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 268 | 350 | $7,000 | $1,036 | 14.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 23 | 23 | $575.00 | $567.75 | 98.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 20 | 23 | $1,380 | $219.86 | 15.9% |
About Dr. Stephen Lang, MD
Dr. Stephen Lang, MD is a Family Medicine healthcare provider based in Carmel, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831270206.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Lang, MD has received a total of $5,628 in payments from pharmaceutical and medical device companies, with $157.34 received in 2024. These payments were reported across 389 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($5,561).
As a Medicare-enrolled provider, Lang has provided services to 3,854 Medicare beneficiaries, totaling 5,172 services with total Medicare billing of $239,150. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Carmel, IN
- Active Since 10/18/2006
- Last Updated 07/18/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1831270206
Products in Payments
- FARXIGA (Drug) $494.86
- JARDIANCE (Drug) $307.99
- XARELTO (Drug) $290.32
- CHANTIX (Drug) $221.66
- BYDUREON (Drug) $212.81
- Natroba (Drug) $200.00
- ADVAIR (Drug) $181.20
- Vascepa (Drug) $179.46
- Victoza (Drug) $158.94
- SHINGRIX (Biological) $144.59
- TRULICITY (Drug) $144.54
- Saxenda (Drug) $139.88
- Aimovig (Biological) $135.41
- Wegovy (Drug) $124.15
- INVOKANA (Drug) $119.14
- Tresiba (Drug) $118.90
- Natesto (Drug) $113.75
- CONTRAVE (Drug) $104.66
- SIGNIA (Device) $100.51
- Trintellix (Drug) $97.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Carmel
Shekar Pushpala, M.d, M.D
Family Medicine — Payments: $239,101
Dr. Jeffery Schoonover, Md, MD
Family Medicine — Payments: $63,293
Peiyi Hu, Md, MD
Family Medicine — Payments: $18,784
Mohammed Tarrabain, Md, MD
Family Medicine — Payments: $15,969
Dr. Steven Delee, Do, DO
Family Medicine — Payments: $12,524
Mary Forkin, Md, MD
Family Medicine — Payments: $12,225